Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Tobacco Products Scientific Advisory Committee

Tobacco Products Scientific Advisory Committee

                        2023 TPSAC Meeting Materials and Information
          2020 TPSAC Meeting Materials and Information
          Charter of the Tobacco Products Scientific Advisory Committee
          Past Meeting Materials: Tobacco Products Scientific Advisory Committee
          Roster of the Tobacco Products Scientific Advisory Committee Home
          Advisory Committees
          Committees and Meeting Materials
          Tobacco Products Scientific Advisory Committee
          Charter of the Tobacco Products Scientific Advisory CommitteeTobacco Products Scientific Advisory Committee Charter of the Tobacco Products Scientific Advisory Committee
  
  	
    Share
    Post
    Linkedin

    Email
    Print**Amended September, 2012**

Authority

The Tobacco Products Scientific Advisory Committee was established under section 917 of the Federal Food, Drug, and Cosmetic Act (FD&C Act)(21 U.S.C. 387q), as added by section 101 of the Family Smoking Prevention and Tobacco Control Act, Pub. L. 111-31. The Committee is also governed by 21 CFR Part 14 and Pub. L. 92-463 (5 U.S.C. App.), the Federal Advisory Committee Act, which sets forth standards for the formation and use of advisory committees.

Objectives and Scope of Activities

The Tobacco Products Scientific Advisory Committee advises the Commissioner or designee in discharging responsibilities as they relate to the regulation of tobacco products.

Description of Duties

The Committee reviews and evaluates safety, dependence, and health issues relating to tobacco products and provides appropriate advice, information and recommendations to the Commissioner of Food and Drugs.

Specifically, the Committee will submit reports or recommendations on tobacco-related topics, including:

The impact of the use of menthol in cigarettes on the public health, including such use among children, African Americans, Hispanics and other racial and ethnic minorities
	The nature and impact of the use of dissolvable tobacco products on the public health, including such use on children
	The effects of the alteration of nicotine yields from tobacco products and whether there is a threshold level below which nicotine yields do not produce dependence on the tobacco product involved
	Any application submitted by a manufacturer for a modified risk tobacco productThe Committee may provide recommendations to the Commissioner regarding any regulations to be promulgated under the act and may review any applications for new tobacco products or petitions for exemption under Section 906(e) of the FD&C Act. The Committee may consider and provide recommendations on any other matter as provided in the Family Smoking Prevention and Tobacco Control Act.

Agency or Official to Whom the Committee Reports

The Committee provides advice to the Commissioner of Food and Drugs.

Support

Management and support services shall be provided by the Center for Tobacco Products, Food and Drug Administration.

Estimated Annual Operating Costs and Staff Years

The estimated annual cost for operating the Committee, including compensation and travel expenses for members, but excluding staff support is $357,832. The estimated person years of staff support required is 4.35, at an estimated cost of $557,227.

Designated Federal Officer

FDA will select a fulltime or permanent part-time Federal employee to serve as the Designated Federal Officer (DFO) to attend each Committee meeting and ensure that all procedures are within applicable statutory, regulatory, and HHS General Administration Manual directives. The DFO will approve and prepare all meeting agendas, call all of the Committee and subcommittee meetings, adjourn any meeting when the DFO determines adjournment to be in the public interest and chair meetings when directed to do so by the official to whom the Committee reports. The DFO shall be present at all meetings of the full committee and subcommittees.

Estimated Number and Frequency of Meetings

Meetings shall be held approximately four times a year. Meetings shall be open to the public except as determined otherwise by the Commissioner or designee in accordance with the Government in the Sunshine Act (5 U.S.C. 552b(c)) and the Federal Advisory Committee Act. Notice of all meetings shall be given to the public. A report will be prepared which will contain, as a minimum, a list of members and their business addresses, the Committee’s functions, the dates and places of meetings, and a summary of the Committee’s activities and recommendations made during the fiscal year. A copy of this report will be provided to the Department Committee Management Officer.

Duration

Continuing; this committee is mandated by statute with no specific end date.

Termination

Section 14 of the Federal Advisory Committee Act does not apply to the duration of this committee, as stated in section 917(D)(3) of the FD&C Act (21 U.S.C. 387q(d)(3)). This charter will remain in effect until amended or terminated by the Commissioner.

Membership and Designation

The Committee shall consist of 12 members including the Chair. Members and the Chair are selected by the Commissioner or designee from among individuals knowledgeable in the fields of medicine, medical ethics, science, or technology involving the manufacture, evaluation, or use of tobacco products.  Members will be invited to serve for overlapping terms of up to four years. Almost all non-Federal members of this committee serve as Special Government Employees. The Committee shall include nine technically qualified voting members, selected by the Commissioner or designee.  The nine voting members shall be physicians, dentists, scientists, or health care professionals practicing in the area of oncology, pulmonology, cardiology, toxicology, pharmacology, addiction, or any other relevant specialty. One member shall be an officer or employee of a state or local government or of the Federal Government. The final voting member shall be a representative of the general public.  In addition to the voting members, the Committee shall include 3 non-voting members who are identified with industry interests. These members shall include one representative of the tobacco manufacturing industry, one representative of the interests of tobacco growers, and one representative of the interests of the small business tobacco manufacturing industry. This final position can be filled on a rotating, sequential basis by representatives of different small business tobacco manufacturers based on areas of expertise relevant to the topics being considered by the Committee. The Commissioner or designee shall have the authority to select, from a group of individuals nominated by industry, the group of representatives eligible to serve as nonvoting representatives of the interests of small business tobacco manufacturers. The Commissioner or designee shall also have the authority to designate which of the eligible representatives will serve as the representative of the interests of the small business tobacco manufacturing industry for a particular Committee meeting based on the area of expertise relevant to the topics being considered by the Committee at that meeting

The Commissioner or designee shall designate one of the voting members of the committee to serve as chairperson.

The Commissioner or designee shall have the authority to select members of other scientific and technical FDA advisory committees (normally not to exceed 10 members) to serve temporarily as voting members and to designate consultants to serve temporarily as voting members when: (1) expertise is required that is not available among current voting standing members of the Committee (when additional voting members are added to the Committee to provide needed expertise, a quorum will be based on the combined total of regular and added members), or (2) to comprise a quorum when, because of unforeseen circumstances, a quorum is or will be lacking. Because of the size of the Committee and the variety in the types of issues it will consider, FDA may, in connection with a particular committee meeting, specify a quorum that is less than a majority of the current voting members. The Agency's regulations (21 CFR §14.22(d)) authorize a committee charter to specify quorum requirements.

Subcommittee

Temporary subcommittees consisting of two or more Committee members may be established by the Commissioner or designee as needed to address specific issues within their respective areas of expertise.

Subcommittees make preliminary recommendations regarding specific issues for subsequent action by the full Committee. The Department Committee Management Officer shall be notified upon establishment of each subcommittee, and shall be provided information on its name, membership, function, and estimated frequency of meetings.

Recordkeeping

The records of the Committee, established subcommittees, or other subgroups of the committee, shall be handled in accordance with General Records Schedule 26, Item 2 or other approved agency records disposition schedule. The records shall be available for public inspection and copying, subject to the Freedom of Information Act, 5 U.S.C. 552.

A report will be prepared containing, as a minimum, a list of members and their business addresses, the Committee’s functions, the dates and places of meetings, and a summary of the Committee’s activities and recommendations made during the fiscal year. A copy of this report will be provided to the Department Committee Management Officer.

Filing Date

Approved:

Dated: September 10, 2012

Jill Hartzler Warner, J.D.

Acting Associate Commissioner for Special Medical Programs, FDA

                                                                                  Content current as of:
      02/05/2019Tobacco Products Scientific Advisory Committee

          
                        2023 TPSAC Meeting Materials and Information
          2020 TPSAC Meeting Materials and Information
          Charter of the Tobacco Products Scientific Advisory Committee
          Past Meeting Materials: Tobacco Products Scientific Advisory Committee
          Roster of the Tobacco Products Scientific Advisory Committee
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop